Administrative Core
行政核心
基本信息
- 批准号:10709228
- 负责人:
- 金额:$ 26.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-19 至 2028-07-31
- 项目状态:未结题
- 来源:
- 关键词:AdministratorAdvocateBasic ScienceBioinformaticsBiostatistics CoreCancer CenterClinicalClinical TrialsCollaborationsCommunicationDevelopmentDisciplineDisputesEnsureEvaluationGoalsInstitutionMalignant neoplasm of ovaryMentorshipMonitorOutcomeOvarianPathologyPatientsPoliciesPolicy ComplianceProceduresProcessQuality ControlRegulationReportingResearchResearch PersonnelResolutionTranslatingUnderrepresented MinorityUniversity of Texas M D Anderson Cancer CenterWomananticancer researchcareerdata qualitydata sharingimprovedinter-institutionalinterdisciplinary approachprogramsquality assurancerecruitsuccesstimeline
项目摘要
Core A: Administrative Core SUMMARY/ ABSTRACT
The overall goal of the MD Anderson Cancer Center SPORE in Ovarian Cancer is to translate high-quality research
into improved clinical outcomes for women with ovarian cancer. To ensure the success of the SPORE, the
Administrative Core will provide effective management and administration of all activities relating to each project,
core, career enhancement and developmental program in the SPORE. The Administrative Core will communicate
and disseminate information between our SPORE investigators and facilitate information sharing and collaborations
with other SPOREs and external collaborators. The Core will provide a platform for integrating diverse scientific
disciplines into a unified multidisciplinary approach for achieving excellence in translational ovarian cancer
research. The Administrative Core will monitor timelines and ensure both basic science and clinical trial aims are
met for all SPORE projects. Co-Core Directors and MPIs, Drs. Anil Sood and Robert Bast, along with Ovarian
SPORE Administrator, Ms. Ersulan Hampton and Ovarian SPORE Scientific Writer, Dr. Robert Langley, will direct
the objectives of the Administrative Core. The objectives of the Core are to: 1) direct the planning and evaluation to
ensure the overall scientific quality and strategic direction of the SPORE; 2) manage all fiscal and budgetary issues
across all Projects, Cores and Developmental Research and Career Enhancement Programs; 3) monitor the data
sharing compliance of the SPORE to adhere to all general governmental and specific NCI regulations and
requirements; 4) coordinate quality assurance activities, including data quality controls with support from the
Bioinformatics and Biostatistics Core and the Pathology Core; 5) serve as the communication hub for the SPORE
to provide up-to-date operating information to investigators; 6) communicate and confer with the NCI Project Officer
and other staff to make certain all necessary reporting requirements are met, including PMCID policy compliance;
7) coordinate the annual process for selection of Developmental Research and Career Enhancement Program
recipients, and establish policies and procedures that result in the successful recruitment of women and
underrepresented minorities to these programs and ensure awardees are supported with outstanding mentorship;
8) ensure the SPORE is integrated in administrative organization of the institution; 9) initiate and coordinate inter-
SPORE and inter-institutional interactions and seminars; 10) facilitate resolution of scientific disputes; and 11)
organize and maintain patient advocate involvement in the SPORE.
核心A:行政核心摘要/摘要
MD Anderson癌症中心在卵巢癌中的总体目标是翻译高质量的研究
改善卵巢癌女性的临床结果。为了确保孢子的成功,
行政核心将提供与每个项目有关的所有活动的有效管理和管理,
核心,孢子中的职业增强和发展计划。行政核心将交流
并在我们的孢子调查人员之间传播信息,并促进信息共享和协作
与其他孢子和外部合作者。核心将为整合多样化的科学提供平台
学科成为统一的多学科方法,以实现转化卵巢癌的卓越
研究。行政核心将监视时间表,并确保基础科学和临床试验目标是
满足所有孢子项目。联合核心总监和MPI,Drs。 Anil Sood和Robert Bast,以及卵巢
孢子管理员,Ersulan Hampton女士和卵巢孢子科学作家Robert Langley博士将导演
行政核心的目标。核心的目标是:1)将计划和评估引导到
确保孢子的整体科学质量和战略方向; 2)管理所有财政和预算问题
在所有项目,核心和发展研究和职业增强计划中; 3)监视数据
分享孢子的遵守情况,以遵守所有一般政府和特定的NCI法规以及
要求; 4)协调质量保证活动,包括数据质量控制
生物信息学和生物统计学核心以及病理核心; 5)充当孢子的通信枢纽
向调查人员提供最新的操作信息; 6)与NCI项目官员进行交流和交流
以及其他工作人员确定所有必要的报告要求,包括PMCID政策合规性;
7)协调选择发展研究和职业增强计划的年度过程
接收者并建立政策和程序,以成功招募妇女和
这些计划的代表人数不足,并确保获得杰出指导的获奖者;
8)确保将孢子纳入机构的行政组织中; 9)启动和协调 -
孢子和机构互动和研讨会; 10)促进解决科学纠纷; 11)
组织并维持患者的主张参与孢子。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANIL K SOOD其他文献
ANIL K SOOD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANIL K SOOD', 18)}}的其他基金
Harnessing the power of exosomes for non-coding RNA delivery
利用外泌体的力量进行非编码 RNA 递送
- 批准号:
9754614 - 财政年份:2017
- 资助金额:
$ 26.06万 - 项目类别:
Harnessing the power of exosomes for non-coding RNA delivery
利用外泌体的力量进行非编码 RNA 递送
- 批准号:
9979631 - 财政年份:2017
- 资助金额:
$ 26.06万 - 项目类别:
Harnessing the power of exosomes for non-coding RNA delivery
利用外泌体的力量进行非编码 RNA 递送
- 批准号:
9388779 - 财政年份:2017
- 资助金额:
$ 26.06万 - 项目类别:
Harnessing the power of exosomes for non-coding RNA delivery
利用外泌体的力量进行非编码 RNA 递送
- 批准号:
10670211 - 财政年份:2017
- 资助金额:
$ 26.06万 - 项目类别:
Project 3: The Role of Macrophages in Resistance to Anti-VEGF Drugs in Ovarian Cancer
项目3:巨噬细胞在卵巢癌抗VEGF药物耐药中的作用
- 批准号:
10005297 - 财政年份:2017
- 资助金额:
$ 26.06万 - 项目类别:
Project 3: The Role of Macrophages in Resistance to Anti-VEGF Drugs in Ovarian Cancer
项目3:巨噬细胞在卵巢癌抗VEGF药物耐药中的作用
- 批准号:
10251116 - 财政年份:2017
- 资助金额:
$ 26.06万 - 项目类别:
相似海外基金
SAR 2023: From Mechanism to Patient-Centered Care: Research in Acupuncture and Traditional East Asian Medicine
SAR 2023:从机制到以患者为中心的护理:针灸和传统东亚医学研究
- 批准号:
10609124 - 财政年份:2023
- 资助金额:
$ 26.06万 - 项目类别:
The 2022 Annual Conference of ISHR-NAS: Advances in Cardiovascular Medicine Through Diversity, Equity, and Inclusion; Focusing on Education and Technological Innovation
ISHR-NAS 2022 年年会:通过多样性、公平和包容性推动心血管医学进展;
- 批准号:
10540615 - 财政年份:2022
- 资助金额:
$ 26.06万 - 项目类别:
2/2 CSUF/UCI-CFCCC Cancer Health Equity Research Partnership (CHERP)
2/2 CSUF/UCI-CFCCC 癌症健康公平研究合作伙伴关系 (CHERP)
- 批准号:
10493213 - 财政年份:2021
- 资助金额:
$ 26.06万 - 项目类别:
1/2 CSUF/UCI-CFCCC Cancer Health Disparities Research Program (CHERP)
1/2 CSUF/UCI-CFCCC 癌症健康差异研究计划 (CHERP)
- 批准号:
10684039 - 财政年份:2021
- 资助金额:
$ 26.06万 - 项目类别:
2/2 CSUF/UCI-CFCCC Cancer Health Equity Research Partnership (CHERP)
2/2 CSUF/UCI-CFCCC 癌症健康公平研究合作伙伴关系 (CHERP)
- 批准号:
10302794 - 财政年份:2021
- 资助金额:
$ 26.06万 - 项目类别: